Latest Breaking News On - Artal group - Page 11 : comparemela.com

AlloVir, Inc (NASDAQ:ALVR) CEO Sells $27,752 07 in Stock

AlloVir, Inc (NASDAQ:ALVR) CEO Sells $27,752 07 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerLeerink partnrsDiana brainardAllovir company profileJpmorgan chase coAllovir incBlackrock incArtal groupVanguard group incGet free reportVanguard groupAllovir daily

IGM Biosciences (NASDAQ:IGMS) Trading 6 7% Higher

IGM Biosciences (NASDAQ:IGMS) Trading 6 7% Higher
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausFred schwarzerBruce keytArtal groupGreat point partnersRoyal bankBiosciences incTd asset management incMorgan stanleySecurities exchange commissionMaven securitiesIgm biosciences incGet free reportExchange commissionManagement inc

Brokerages Set CAVA Group, Inc (NYSE:CAVA) PT at $48 20

CAVA Group, Inc. (NYSE:CAVA – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the thirteen research firms that are presently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 1 year […]

District of columbiaUnited statesWilliam blairRaymond jamesRevolution growth management company incGroup dailyGroup incVanguard group incCapital research global investorsGroup tradingArtal groupCava group incCapital international investorsGet free reportGrowth management companyResearch global investors

Scholar Rock s (SRRK) Outperform Rating Reiterated at Wedbush

Scholar Rock (NASDAQ:SRRK – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Wedbush in a report issued on Tuesday, RTT News reports. They currently have a $23.00 price target on the stock. Wedbush’s price target would suggest a potential upside of 56.14% from the company’s previous close. Several other research […]

Edwardh mylesBlackrock incArtal groupRedmile groupJefferies financial groupScholar rock holding corporationPricet rowe associates incSecurities exchange commissionScholar rockGet free reportFinancial groupExchange commissionRock holding corporationScholar rock dailyNasdaq srrkReiterated rating

IGM Biosciences, Inc (NASDAQ:IGMS) Short Interest Up 7 9% in December

IGM Biosciences, Inc (NASDAQ:IGMS) Short Interest Up 7 9% in December
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesFred schwarzerStifel nicolausBruce keytIgm biosciences incRoyal bankArtal groupSecurities exchange commissionMorgan stanleyTd asset management incMaven securitiesBiosciences incGreat point partnersGet free reportExchange commissionManagement inc